The FDA nod applies to Bayer's Medrad Stellant Flex CT injectors used with the company's Certegra workstation software for contrast-enhanced mammography. Contrast mammography enables better visualization of breast abnormalities that might not normally be visualized on standard mammograms.
Bayer believes that using a contrast injection system like Stellant Flex provides benefits over manually administering contrast, such as accurate dose administration. The company notes that contrast-enhanced mammography has been shown to be more accurate than either standard mammography or breast ultrasound.
Copyright © 2019 AuntMinnie.com